Podcast
Questions and Answers
What is the fasting plasma glucose (FPG) range for diagnosing Type 2 Diabetes Mellitus (T2DM)?
What is the fasting plasma glucose (FPG) range for diagnosing Type 2 Diabetes Mellitus (T2DM)?
- 100-125 mg/dL (correct)
- 120-140 mg/dL
- 90-110 mg/dL
- 130-150 mg/dL
What is the HbA1c level that indicates prediabetes?
What is the HbA1c level that indicates prediabetes?
- 5.7% (correct)
- 6.5%
- 4.9%
- 6.0%
Which postprandial oral glucose tolerance test result indicates Type 2 Diabetes Mellitus (T2DM)?
Which postprandial oral glucose tolerance test result indicates Type 2 Diabetes Mellitus (T2DM)?
- 200-250 mg/dL (correct)
- 250-300 mg/dL
- 100-120 mg/dL
- 140-199 mg/dL
What is a limitation of using HbA1c for diagnosing diabetes?
What is a limitation of using HbA1c for diagnosing diabetes?
To minimize hypoglycemia and weight gain in Type 2 Diabetes Mellitus (T2DM) patients, which class of medications like Empagliflozin belong to?
To minimize hypoglycemia and weight gain in Type 2 Diabetes Mellitus (T2DM) patients, which class of medications like Empagliflozin belong to?
What is the typical decrease in A1c when using SGLT2-i as monotherapy?
What is the typical decrease in A1c when using SGLT2-i as monotherapy?
Which of the following SGLT2-i has the maximum daily dose that depends on GFR?
Which of the following SGLT2-i has the maximum daily dose that depends on GFR?
Which class of medication should be avoided in combination with DPP4i for T2DM treatment?
Which class of medication should be avoided in combination with DPP4i for T2DM treatment?
Which medication class is most effective for minimizing weight gain or promoting weight loss in T2DM treatment?
Which medication class is most effective for minimizing weight gain or promoting weight loss in T2DM treatment?
Which medication class should be considered first for minimizing cost in T2DM treatment?
Which medication class should be considered first for minimizing cost in T2DM treatment?
What is the recommended HbA1c level for diagnosing type 2 diabetes mellitus (T2DM)?
What is the recommended HbA1c level for diagnosing type 2 diabetes mellitus (T2DM)?
What are the limitations of using HbA1c for diagnosing T2DM?
What are the limitations of using HbA1c for diagnosing T2DM?
Which class of medications for T2DM has been shown to have cardiovascular benefits?
Which class of medications for T2DM has been shown to have cardiovascular benefits?
What are the primary treatment goals for T2DM?
What are the primary treatment goals for T2DM?
How can hypoglycemia and weight gain be minimized in the treatment of T2DM?
How can hypoglycemia and weight gain be minimized in the treatment of T2DM?
What is the main diagnostic criterion for Type 2 Diabetes Mellitus (T2DM)?
What is the main diagnostic criterion for Type 2 Diabetes Mellitus (T2DM)?
Which of the following is NOT a limitation of using HbA1c for diabetes management?
Which of the following is NOT a limitation of using HbA1c for diabetes management?
Which class of medications for T2DM primarily targets the kidneys to reduce glucose levels in the blood?
Which class of medications for T2DM primarily targets the kidneys to reduce glucose levels in the blood?
What is the primary treatment goal for T2DM, according to the American Diabetes Association (ADA)?
What is the primary treatment goal for T2DM, according to the American Diabetes Association (ADA)?
Which of the following strategies can help minimize hypoglycemia and weight gain in T2DM patients?
Which of the following strategies can help minimize hypoglycemia and weight gain in T2DM patients?
What should be avoided combining with DPP4 inhibitors for Type 2 Diabetes Mellitus (T2DM) treatment?
What should be avoided combining with DPP4 inhibitors for Type 2 Diabetes Mellitus (T2DM) treatment?
Which medication class is most effective for minimizing weight gain or promoting weight loss in T2DM treatment?
Which medication class is most effective for minimizing weight gain or promoting weight loss in T2DM treatment?
What is a limitation of using HbA1c for diagnosing diabetes?
What is a limitation of using HbA1c for diagnosing diabetes?
Which SGLT2 inhibitor has the dosing regimen of 5-10 mg daily in the morning?
Which SGLT2 inhibitor has the dosing regimen of 5-10 mg daily in the morning?
What is the primary treatment goal for Type 2 Diabetes Mellitus (T2DM) patients according to the American Diabetes Association?
What is the primary treatment goal for Type 2 Diabetes Mellitus (T2DM) patients according to the American Diabetes Association?
What diagnostic criterion is essential for Type 2 Diabetes Mellitus (T2DM) diagnosis besides HbA1c?
What diagnostic criterion is essential for Type 2 Diabetes Mellitus (T2DM) diagnosis besides HbA1c?
What is the primary treatment goal for minimizing hypoglycemia and weight gain in Type 2 Diabetes Mellitus (T2DM)?
What is the primary treatment goal for minimizing hypoglycemia and weight gain in Type 2 Diabetes Mellitus (T2DM)?
Which class of medications for T2DM primarily targets the kidneys to reduce glucose levels in the blood?
Which class of medications for T2DM primarily targets the kidneys to reduce glucose levels in the blood?
What is considered a limitation of using HbA1c for diagnosing Type 2 Diabetes Mellitus (T2DM)?
What is considered a limitation of using HbA1c for diagnosing Type 2 Diabetes Mellitus (T2DM)?
Which criteria are used to diagnose Type 2 Diabetes Mellitus (T2DM) based on random blood glucose levels?
Which criteria are used to diagnose Type 2 Diabetes Mellitus (T2DM) based on random blood glucose levels?
What fasting plasma glucose (FPG) range indicates a diagnosis of Type 2 Diabetes Mellitus (T2DM)?
What fasting plasma glucose (FPG) range indicates a diagnosis of Type 2 Diabetes Mellitus (T2DM)?
How often should testing be performed for patients with normal results to check for prediabetes, according to the guidelines?
How often should testing be performed for patients with normal results to check for prediabetes, according to the guidelines?
Which class of medications is most effective for minimizing hypoglycemia and weight gain in T2DM treatment?
Which class of medications is most effective for minimizing hypoglycemia and weight gain in T2DM treatment?
What is the primary treatment goal for T2DM, according to the American Diabetes Association (ADA)?
What is the primary treatment goal for T2DM, according to the American Diabetes Association (ADA)?
Which of the following SGLT2 inhibitors has the maximum daily dose that depends on GFR?
Which of the following SGLT2 inhibitors has the maximum daily dose that depends on GFR?
What is the recommended HbA1c level for diagnosing type 2 diabetes mellitus (T2DM)?
What is the recommended HbA1c level for diagnosing type 2 diabetes mellitus (T2DM)?
What are the primary treatment goals for T2DM?
What are the primary treatment goals for T2DM?
What is a limitation of using HbA1c for diagnosing diabetes?
What is a limitation of using HbA1c for diagnosing diabetes?
What is the primary treatment goal in Type 2 Diabetes Mellitus (T2DM) for minimizing hypoglycemia and weight gain?
What is the primary treatment goal in Type 2 Diabetes Mellitus (T2DM) for minimizing hypoglycemia and weight gain?
Which medication class is most suitable for minimizing weight gain or promoting weight loss in T2DM treatment without established ASCVD, CKD, or HF?
Which medication class is most suitable for minimizing weight gain or promoting weight loss in T2DM treatment without established ASCVD, CKD, or HF?
What is a limitation of utilizing HbA1c in the management of T2DM?
What is a limitation of utilizing HbA1c in the management of T2DM?
Which of the following is a diagnostic criterion besides HbA1c that is essential for diagnosing T2DM?
Which of the following is a diagnostic criterion besides HbA1c that is essential for diagnosing T2DM?
For patients with T2DM not at goal, and considering minimizing cost without established ASCVD, CKD, or HF, which medication class should be avoided?
For patients with T2DM not at goal, and considering minimizing cost without established ASCVD, CKD, or HF, which medication class should be avoided?
If a patient with T2DM is not at goal and aiming to minimize hypoglycemia without established ASCVD, CKD, or HF, which combination of medications should be considered?
If a patient with T2DM is not at goal and aiming to minimize hypoglycemia without established ASCVD, CKD, or HF, which combination of medications should be considered?
What is a possible limitation of using HbA1c for diagnosing Type 2 Diabetes Mellitus (T2DM)?
What is a possible limitation of using HbA1c for diagnosing Type 2 Diabetes Mellitus (T2DM)?
To minimize hypoglycemia and weight gain in Type 2 Diabetes Mellitus (T2DM) patients, which class of medications would be beneficial?
To minimize hypoglycemia and weight gain in Type 2 Diabetes Mellitus (T2DM) patients, which class of medications would be beneficial?
What fasting plasma glucose (FPG) range would indicate a diagnosis of Type 2 Diabetes Mellitus (T2DM)?
What fasting plasma glucose (FPG) range would indicate a diagnosis of Type 2 Diabetes Mellitus (T2DM)?
Which of the following postprandial oral glucose tolerance test results indicates Type 2 Diabetes Mellitus (T2DM)?
Which of the following postprandial oral glucose tolerance test results indicates Type 2 Diabetes Mellitus (T2DM)?
What is the primary treatment goal for Type 2 Diabetes Mellitus (T2DM) patients according to the guidelines?
What is the primary treatment goal for Type 2 Diabetes Mellitus (T2DM) patients according to the guidelines?
Which of the following is a criterion essential for diagnosing Type 2 Diabetes Mellitus (T2DM) besides HbA1c?
Which of the following is a criterion essential for diagnosing Type 2 Diabetes Mellitus (T2DM) besides HbA1c?
What is a potential limitation of using HbA1c for diagnosing Type 2 Diabetes Mellitus (T2DM), especially in certain populations?
What is a potential limitation of using HbA1c for diagnosing Type 2 Diabetes Mellitus (T2DM), especially in certain populations?
Which class of medications for T2DM primarily targets the kidneys to reduce glucose levels in the blood?
Which class of medications for T2DM primarily targets the kidneys to reduce glucose levels in the blood?
Besides HbA1c, what is another essential diagnostic criterion for diagnosing Type 2 Diabetes Mellitus (T2DM)?
Besides HbA1c, what is another essential diagnostic criterion for diagnosing Type 2 Diabetes Mellitus (T2DM)?
To minimize hypoglycemia and weight gain in Type 2 Diabetes Mellitus (T2DM) patients, which medication class should be considered first?
To minimize hypoglycemia and weight gain in Type 2 Diabetes Mellitus (T2DM) patients, which medication class should be considered first?
Which criteria are used to diagnose Type 2 Diabetes Mellitus (T2DM) based on random blood glucose levels?
Which criteria are used to diagnose Type 2 Diabetes Mellitus (T2DM) based on random blood glucose levels?
What is a common limitation of using HbA1c for diabetes management that relates to patient variability?
What is a common limitation of using HbA1c for diabetes management that relates to patient variability?
What is the minimum age recommended for starting testing for diabetes in all patients?
What is the minimum age recommended for starting testing for diabetes in all patients?
Which of the following factors is NOT considered in the ADA criteria for testing adults for diabetes?
Which of the following factors is NOT considered in the ADA criteria for testing adults for diabetes?
Besides HbA1c, which test result indicates a diagnosis of prediabetes?
Besides HbA1c, which test result indicates a diagnosis of prediabetes?
What fasting plasma glucose (FPG) level indicates a diagnosis of Type 2 Diabetes Mellitus?
What fasting plasma glucose (FPG) level indicates a diagnosis of Type 2 Diabetes Mellitus?
What is a limitation of using HbA1c for diagnosing Type 2 Diabetes Mellitus, especially in certain populations?
What is a limitation of using HbA1c for diagnosing Type 2 Diabetes Mellitus, especially in certain populations?
What is a key consideration for the initiation and maximum dosing of SGLT2 inhibitors in T2DM?
What is a key consideration for the initiation and maximum dosing of SGLT2 inhibitors in T2DM?
In T2DM management, which medication class should be avoided in combination with DPP4 inhibitors?
In T2DM management, which medication class should be avoided in combination with DPP4 inhibitors?
For T2DM patients aiming to minimize hypoglycemia without established cardiovascular disease, chronic kidney disease, or heart failure, which medication class combination should be considered?
For T2DM patients aiming to minimize hypoglycemia without established cardiovascular disease, chronic kidney disease, or heart failure, which medication class combination should be considered?
Besides HbA1c, what other diagnostic criterion is essential for diagnosing Type 2 Diabetes Mellitus (T2DM)?
Besides HbA1c, what other diagnostic criterion is essential for diagnosing Type 2 Diabetes Mellitus (T2DM)?
What is a common limitation of using HbA1c for diabetes management that relates to certain patient populations?
What is a common limitation of using HbA1c for diabetes management that relates to certain patient populations?
Which of the following is NOT a primary treatment goal for Type 2 Diabetes Mellitus (T2DM)?
Which of the following is NOT a primary treatment goal for Type 2 Diabetes Mellitus (T2DM)?
Which medication class has been shown to have cardiovascular benefits in addition to glycemic control for T2DM patients?
Which medication class has been shown to have cardiovascular benefits in addition to glycemic control for T2DM patients?
Which of the following is NOT a limitation of using HbA1c for diagnosing T2DM?
Which of the following is NOT a limitation of using HbA1c for diagnosing T2DM?
Which of the following SGLT2-i has the maximum daily dose that depends on GFR?
Which of the following SGLT2-i has the maximum daily dose that depends on GFR?
Which of the following is NOT a diagnostic criterion for T2DM besides HbA1c?
Which of the following is NOT a diagnostic criterion for T2DM besides HbA1c?
What is the primary treatment goal for Type 2 Diabetes Mellitus (T2DM) according to the American Diabetes Association?
What is the primary treatment goal for Type 2 Diabetes Mellitus (T2DM) according to the American Diabetes Association?
Which class of medications for T2DM has been shown to have cardiovascular benefits?
Which class of medications for T2DM has been shown to have cardiovascular benefits?
Which diagnostic criterion is essential for Type 2 Diabetes Mellitus (T2DM) diagnosis besides HbA1c?
Which diagnostic criterion is essential for Type 2 Diabetes Mellitus (T2DM) diagnosis besides HbA1c?
What is a limitation of using HbA1c for diagnosing Type 2 Diabetes Mellitus (T2DM)?
What is a limitation of using HbA1c for diagnosing Type 2 Diabetes Mellitus (T2DM)?
To minimize hypoglycemia and weight gain in Type 2 Diabetes Mellitus (T2DM) patients, which class of medications would be beneficial?
To minimize hypoglycemia and weight gain in Type 2 Diabetes Mellitus (T2DM) patients, which class of medications would be beneficial?
What is the primary treatment goal in Type 2 Diabetes Mellitus (T2DM) for minimizing hypoglycemia and weight gain?
What is the primary treatment goal in Type 2 Diabetes Mellitus (T2DM) for minimizing hypoglycemia and weight gain?
Which class of medications for T2DM primarily targets the kidneys to reduce glucose levels in the blood?
Which class of medications for T2DM primarily targets the kidneys to reduce glucose levels in the blood?
Which class of medications for T2DM has been shown to have cardiovascular benefits?
Which class of medications for T2DM has been shown to have cardiovascular benefits?
Which medication class is most effective for minimizing weight gain or promoting weight loss in T2DM treatment?
Which medication class is most effective for minimizing weight gain or promoting weight loss in T2DM treatment?
Besides HbA1c, what other diagnostic criterion is essential for diagnosing Type 2 Diabetes Mellitus (T2DM)?
Besides HbA1c, what other diagnostic criterion is essential for diagnosing Type 2 Diabetes Mellitus (T2DM)?
What is the typical decrease in A1c when using SGLT2-i as monotherapy?
What is the typical decrease in A1c when using SGLT2-i as monotherapy?
Which SGLT2 inhibitor has the dosing regimen of 5-10 mg daily in the morning?
Which SGLT2 inhibitor has the dosing regimen of 5-10 mg daily in the morning?
For T2DM patients aiming to minimize hypoglycemia without established cardiovascular disease, chronic kidney disease, or heart failure, which medication class combination should be considered?
For T2DM patients aiming to minimize hypoglycemia without established cardiovascular disease, chronic kidney disease, or heart failure, which medication class combination should be considered?
Which medication class is most suitable for minimizing weight gain or promoting weight loss in T2DM treatment without established ASCVD, CKD, or HF?
Which medication class is most suitable for minimizing weight gain or promoting weight loss in T2DM treatment without established ASCVD, CKD, or HF?
What is a limitation of using HbA1c for diagnosing Type 2 Diabetes Mellitus (T2DM)?
What is a limitation of using HbA1c for diagnosing Type 2 Diabetes Mellitus (T2DM)?
Empagliflozin is a medication used for the treatment of type 2 diabetes mellitus.
Empagliflozin is a medication used for the treatment of type 2 diabetes mellitus.
Canagliflozin is a type of GLP-1 receptor agonist for type 2 diabetes treatment.
Canagliflozin is a type of GLP-1 receptor agonist for type 2 diabetes treatment.
Saxagliptin has been shown to improve cardiovascular outcomes in patients with type 2 diabetes mellitus.
Saxagliptin has been shown to improve cardiovascular outcomes in patients with type 2 diabetes mellitus.
Liraglutide has been associated with cardiovascular benefits in patients with type 2 diabetes mellitus.
Liraglutide has been associated with cardiovascular benefits in patients with type 2 diabetes mellitus.
Dapagliflozin is a medication that primarily targets the kidneys to reduce glucose levels in the blood.
Dapagliflozin is a medication that primarily targets the kidneys to reduce glucose levels in the blood.
Semaglutide is a DPP-4 inhibitor used in the management of type 2 diabetes mellitus.
Semaglutide is a DPP-4 inhibitor used in the management of type 2 diabetes mellitus.
SGLT2 inhibitors are commonly associated with weight gain in patients with type 2 diabetes mellitus.
SGLT2 inhibitors are commonly associated with weight gain in patients with type 2 diabetes mellitus.
Empagliflozin is one of the SGLT2 inhibitors that have shown cardiovascular benefits in type 2 diabetes mellitus.
Empagliflozin is one of the SGLT2 inhibitors that have shown cardiovascular benefits in type 2 diabetes mellitus.
Taking SGLT2 inhibitors may contribute to a reduced risk of cardiovascular events in individuals with type 2 diabetes mellitus.
Taking SGLT2 inhibitors may contribute to a reduced risk of cardiovascular events in individuals with type 2 diabetes mellitus.
Canagliflozin, as an SGLT2 inhibitor, is ineffective in lowering blood glucose levels in patients with type 2 diabetes mellitus.
Canagliflozin, as an SGLT2 inhibitor, is ineffective in lowering blood glucose levels in patients with type 2 diabetes mellitus.
Sulfonylureas are the most suitable medication class for minimizing weight gain or promoting weight loss in T2DM treatment without established ASCVD, CKD, or HF.
Sulfonylureas are the most suitable medication class for minimizing weight gain or promoting weight loss in T2DM treatment without established ASCVD, CKD, or HF.
One of the diagnostic criteria for T2DM besides HbA1c is fasting plasma glucose (FPG) level.
One of the diagnostic criteria for T2DM besides HbA1c is fasting plasma glucose (FPG) level.
Meglitinides are a medication class primarily targeting the kidneys to reduce glucose levels in the blood for T2DM.
Meglitinides are a medication class primarily targeting the kidneys to reduce glucose levels in the blood for T2DM.
A diagnostic criterion essential for T2DM diagnosis besides HbA1c is postprandial oral glucose tolerance test results.
A diagnostic criterion essential for T2DM diagnosis besides HbA1c is postprandial oral glucose tolerance test results.
Heart failure (HF) is one of the diagnostic criteria for T2DM diagnosis.
Heart failure (HF) is one of the diagnostic criteria for T2DM diagnosis.
A1c levels remain constant when using SGLT2 inhibitors as monotherapy for T2DM.
A1c levels remain constant when using SGLT2 inhibitors as monotherapy for T2DM.
Alpha glucosidase inhibitors are effective in lowering blood glucose levels in patients with T2DM.
Alpha glucosidase inhibitors are effective in lowering blood glucose levels in patients with T2DM.
Hemoglobin A1c (HbA1c) is the only diagnostic criterion for T2DM diagnosis.
Hemoglobin A1c (HbA1c) is the only diagnostic criterion for T2DM diagnosis.
Thiazolidinediones (TZDs) have been shown to have cardiovascular benefits in addition to glycemic control for T2DM patients.
Thiazolidinediones (TZDs) have been shown to have cardiovascular benefits in addition to glycemic control for T2DM patients.
Self Monitoring Blood Glucose (SMBG) is one of the primary treatment goals for T2DM.
Self Monitoring Blood Glucose (SMBG) is one of the primary treatment goals for T2DM.
Which class of medications for T2DM primarily targets the kidneys to reduce glucose levels in the blood?
Which class of medications for T2DM primarily targets the kidneys to reduce glucose levels in the blood?
What is the primary treatment goal for Type 2 Diabetes Mellitus (T2DM) according to the American Diabetes Association (ADA)?
What is the primary treatment goal for Type 2 Diabetes Mellitus (T2DM) according to the American Diabetes Association (ADA)?
Which of the following strategies can help minimize hypoglycemia and weight gain in T2DM patients?
Which of the following strategies can help minimize hypoglycemia and weight gain in T2DM patients?
What is the typical decrease in A1c when using SGLT2-i as monotherapy?
What is the typical decrease in A1c when using SGLT2-i as monotherapy?
Which class of medications for T2DM has been shown to have cardiovascular benefits?
Which class of medications for T2DM has been shown to have cardiovascular benefits?
Which medication class should be considered first for minimizing cost in T2DM treatment?
Which medication class should be considered first for minimizing cost in T2DM treatment?
What is the primary treatment goal for minimizing hypoglycemia and weight gain in Type 2 Diabetes Mellitus (T2DM)?
What is the primary treatment goal for minimizing hypoglycemia and weight gain in Type 2 Diabetes Mellitus (T2DM)?
What is a limitation of utilizing HbA1c in the management of T2DM?
What is a limitation of utilizing HbA1c in the management of T2DM?
Which diagnostic criterion is essential for Type 2 Diabetes Mellitus (T2DM) diagnosis besides HbA1c?
Which diagnostic criterion is essential for Type 2 Diabetes Mellitus (T2DM) diagnosis besides HbA1c?
What is considered a limitation of using HbA1c for diagnosing Type 2 Diabetes Mellitus (T2DM)?
What is considered a limitation of using HbA1c for diagnosing Type 2 Diabetes Mellitus (T2DM)?
Which medication class primarily targets the kidneys to reduce glucose levels in the blood for T2DM patients?
Which medication class primarily targets the kidneys to reduce glucose levels in the blood for T2DM patients?
Which SGLT2 inhibitor has a dosing regimen of 5-10 mg daily in the morning?
Which SGLT2 inhibitor has a dosing regimen of 5-10 mg daily in the morning?
What is the typical decrease in A1c when using SGLT2i as monotherapy?
What is the typical decrease in A1c when using SGLT2i as monotherapy?
Which of the following SGLT2 inhibitors has a maximum daily dose that depends on GFR?
Which of the following SGLT2 inhibitors has a maximum daily dose that depends on GFR?
Which class of medications for T2DM has been shown to have cardiovascular benefits?
Which class of medications for T2DM has been shown to have cardiovascular benefits?
What is the primary treatment goal for T2DM patients according to the American Diabetes Association (ADA)?
What is the primary treatment goal for T2DM patients according to the American Diabetes Association (ADA)?
What is the fasting plasma glucose (FPG) range for diagnosing Type 2 Diabetes Mellitus (T2DM)?
What is the fasting plasma glucose (FPG) range for diagnosing Type 2 Diabetes Mellitus (T2DM)?
Which medication class is most effective for minimizing weight gain or promoting weight loss in T2DM treatment?
Which medication class is most effective for minimizing weight gain or promoting weight loss in T2DM treatment?
Which class of medication should be avoided in combination with DPP4i for T2DM treatment?
Which class of medication should be avoided in combination with DPP4i for T2DM treatment?
What is a limitation of utilizing HbA1c in the management of T2DM?
What is a limitation of utilizing HbA1c in the management of T2DM?
Flashcards are hidden until you start studying
